Parasympathomimetics and Parasympatholytics: Classification, Examples, and Historical Context

Parasympathomimetics and Parasympatholytics: Classification, Examples, and Historical Context

Introduction

Title: Understanding Parasympathomimetics and Parasympatholytics

Objective: Explore the concepts of Parasympathomimetics and Parasympatholytics, their classifications, clinical uses, and key examples.
Context: These drugs affect the parasympathetic nervous system (PNS), which is responsible for "rest and digest" activities. Understanding these drugs is critical for treating various diseases, including those affecting heart rate, digestion, and the eyes.

Overview of the Parasympathetic Nervous System

Definition:

The parasympathetic nervous system (PNS) is one of the two branches of the autonomic nervous system (ANS), responsible for rest and digest functions. It promotes relaxation, digestion, energy conservation, and recuperation.

Key Functions:

Decreases heart rate (via vagus nerve and acetylcholine)
Stimulates digestion (via increased saliva and gastric juices)
Pupillary constriction (via acetylcholine binding to receptors in the eye)

Example:

After a meal, the PNS helps increase digestive enzyme production, slow the heart rate, and enhance nutrient absorption.

What Are Parasympathomimetics?

Definition:

Parasympathomimetics (also called cholinomimetics) are drugs that mimic the effects of acetylcholine (ACh), the primary neurotransmitter of the parasympathetic nervous system.
These drugs stimulate muscarinic and nicotinic receptors in the body, mimicking the actions of the parasympathetic nervous system.

Mechanism of Action:

Direct Acting: These drugs directly stimulate muscarinic receptors, leading to effects like increased saliva, slowing of the heart rate, and stimulation of gastrointestinal motility.
Indirect Acting: These drugs inhibit acetylcholinesterase (the enzyme that breaks down acetylcholine), thereby increasing the amount of acetylcholine available at the synapse.

Classification of Parasympathomimetics

1. Direct-Acting Parasympathomimetics:

These drugs act directly on muscarinic receptors.

Examples:

Pilocarpine: Used to treat glaucoma (induces pupil constriction and reduces intraocular pressure).
Bethanechol: Used to treat urinary retention (stimulates bladder contractions).

2. Indirect-Acting Parasympathomimetics (Acetylcholinesterase Inhibitors):

These drugs inhibit the enzyme acetylcholinesterase, which breaks down acetylcholine. This results in prolonged stimulation of the parasympathetic system.

Examples:

Physostigmine: Used to treat glaucoma and Alzheimer’s disease by enhancing acetylcholine availability in the brain.
Neostigmine: Used to treat myasthenia gravis, a condition where acetylcholine receptors are damaged.

Clinical Uses of Parasympathomimetics

Examples of Clinical Applications:

Pilocarpine (Direct-Acting):

Used to treat glaucoma by reducing intraocular pressure.
Historical Context: Pilocarpine was first isolated from the Pilocarpus jaborandi plant in the early 19th century and became the first-line treatment for glaucoma.

Neostigmine (Indirect-Acting):

Used in Myasthenia Gravis: This drug helps increase acetylcholine levels at the neuromuscular junction, improving muscle strength.
Historical Story: The discovery of acetylcholinesterase inhibitors marked a major advancement in understanding the neuromuscular transmission. Neostigmine was developed to enhance acetylcholine activity in the treatment of conditions like myasthenia gravis.

Example:

Alzheimer’s disease: Donepezil, an acetylcholinesterase inhibitor, is used to manage symptoms by increasing acetylcholine availability in the brain, potentially improving cognition.

What Are Parasympatholytics?

Definition:

Parasympatholytics (also called anticholinergics) are drugs that block the effects of acetylcholine by inhibiting muscarinic receptors. They oppose the actions of the parasympathetic nervous system.

Mechanism of Action:

These drugs block the action of acetylcholine at muscarinic receptors, leading to effects such as increased heart rate, decreased secretions, and relaxation of smooth muscles.

Classification of Parasympatholytics

1. Non-Selective Muscarinic Antagonists:

These block all muscarinic receptors, leading to a wide range of effects.

Examples:

Atropine: Used to increase heart rate (e.g., in cases of bradycardia) and as a pre-anesthetic to reduce salivation.
Scopolamine: Used to prevent motion sickness by blocking muscarinic receptors in the brain.

2. Selective Muscarinic Antagonists:

These drugs selectively block specific muscarinic receptors, offering more targeted effects.

Examples:

Ipratropium: Used in COPD and asthma to relax bronchial smooth muscles and reduce mucus secretion.
Oxybutynin: Used to treat overactive bladder by blocking muscarinic receptors in the bladder.

Clinical Uses of Parasympatholytics

Examples of Clinical Applications:

Atropine:

Used in Cardiac Arrest: Atropine increases heart rate in cases of bradycardia.
Historical Context: Atropine has been used for centuries. It was derived from the belladonna plant and has been used in medicine since the 19th century to treat a variety of conditions, including as a pre-anesthetic agent.

Scopolamine:

Used for motion sickness or as a pre-anesthetic to prevent nausea.
Historical Story: In ancient Rome, the extract from belladonna (which contains scopolamine) was used in rituals for its sedative effects.

Example:

Ipratropium and Tiotropium are commonly prescribed for chronic obstructive pulmonary disease (COPD) to help with bronchodilation and reduce airway secretions.

Side Effects and Considerations

Parasympathomimetics (Cholinomimetics) Side Effects:

Bradycardia (slowed heart rate)
Excessive salivation
Gastrointestinal cramping or diarrhea
Hypotension (low blood pressure)

Parasympatholytics (Anticholinergics) Side Effects:

Dry mouth
Blurred vision (due to pupil dilation)
Constipation
Urinary retention
Tachycardia (increased heart rate)

Example:

Atropine overdose can lead to dry mouth, blurred vision, and urinary retention, as it blocks normal parasympathetic actions.

Summary and Conclusion

Parasympathomimetics (cholinomimetics) stimulate the parasympathetic system, promoting rest and digest functions, and can be either direct or indirect acting.
Parasympatholytics (anticholinergics) inhibit the parasympathetic system, leading to effects like increased heart rate and reduced secretions.
These drugs have diverse therapeutic applications, from treating glaucoma and myasthenia gravis to managing COPD and motion sickness.

Historical Perspective: The use of atropine and scopolamine from ancient plants such as belladonna laid the groundwork for modern pharmacology.

END OF THE CHAPTER

Owner

Hi. I’m Writer of Researchsop.com. ’ ’ Please share these SOPs to all concern pharma people for their development. I like to fullfill the need of curious people. These things inspire me to make things looks better.